Viome Life Sciences
- Company typePrivate
- Founded2016
- HeadquartersBellevue, United States
- Headcount101–250
- GTM typeB2B and B2C
- OfferingServices
Viome Life Sciences firmographics
Firmographics- Name
- Viome Life Sciences
- Legal name
- Viome Life Sciences, Inc.
- Website
- https://viomelifesciences.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Viome Life Sciences industry classification
Industry- Product category
- Personalized Health Diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
- akta.pro secondary industries
- Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI), Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
Keywords
Where Viome Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Bellevue
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Viome Life Sciences business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Revenue model
- At-home Testing Kits: Viome generates revenue through direct-to-consumer at-home microbiome and gene expression test kits. Customers purchase tests and receive personalized dietary and supplementation recommendations based on gut, oral, and cellular health analysis.
- Precision Health Testing (Viome Pro): B2B revenue from healthcare providers who order comprehensive molecular health tests for their patients through integrated practice management tools.
- Supplements/Personalized Nutrition Products: Revenue from personalized supplement recommendations and products upsold to customers based on their test results. The review notes aggressive supplement upselling as part of the business model.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Full Body Intelligence Test |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels3 records
Viome Life Sciences product offering
Product offeringCore offering
Viome Life Sciences provides at-home microbiome and gene expression tests that use metatranscriptomic RNA sequencing combined with an AI-driven recommendation engine to deliver personalized dietary, supplementation, and precision health insights. Through its Viome Pro channel, it offers healthcare providers molecular health tests (Precision Health PRO, Gut Health PRO, Oral Health Pro) for preventive care and early disease detection, including the only test for oral and throat cancer using molecular analysis.
Product overview
Viome Life Sciences offers a platform-plus-modules architecture centered on RNA sequencing and AI-powered molecular health analysis. The core offerings include Viome® Precision Health PRO (comprehensive cellular and microbiome analysis), Viome® Gut Health PRO (gut-focused analysis), and Viome® Oral Health Pro (oral microbiome and cancer detection), all powered by proprietary RNA sequencing technology and advanced AI. The Full Body Intelligence Test serves as the consumer-facing at-home testing product, while the acquired Naring Health Inc. brand reinforces the personalized health solutions portfolio.
Differentiator
Problem solved
Functional benefit
Brands
- Viome Pro: Precision health solutions for healthcare providers including Viome Precision Health PRO, Gut Health PRO, and Oral Health Pro molecular tests.
- Viome Precision Health PRO
- Gut Health PRO
- Oral Health Pro
- Full Body Intelligence
Products and services
- Viome Precision Health PRO Comprehensive cellular health and microbiome analysis with RNA and AI technologies that provides healthcare providers with 360-degree multi-system analysis, showing root causes and associated risk factors of chronic diseases, along with longevity assessment and precision nutrition recommendations based on over 10,000 biological data points per person.
- Viome Gut Health PRO Gut-focused molecular analysis for healthcare providers showing root causes and associated factors for gastrointestinal diseases, including data-driven analysis of microbiome functional pathways and precision nutrition and treatment recommendations for chronic gastrointestinal conditions.
- Viome Oral Health Pro Oral microbiome molecular analysis test for healthcare providers that detects oral and throat cancer early, enhances periodontal care with objective molecular insights, and identifies oral-systemic health associations through deep molecular analysis.
- Full Body Intelligence Test AI-driven at-home test for consumers that uses RNA sequencing from stool, saliva, and blood samples to detect inflammation, microbial imbalance, and cellular dysfunction, providing personalized dietary and supplementation recommendations based on a decade of research and proprietary technology.
- Personalized Supplement Recommendations and Products Personalized dietary supplements and nutrition products recommended to customers based on their individual test results, representing a recurring revenue stream tied to at-home test purchases.
Quantifiable outcome
- Real-world evidence analysis of over 10,000 relevant biological data points per person
- +2 more outcomes
Companies that use Viome Life Sciences
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
Viome Life Sciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature6 records
Viome Life Sciences partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Naring Health Inc.coreViome Life Sciences Inc. acquired Naring Health Inc. in November 2023 to strengthen its personalized health solutions offerings. This acquisition reinforced Viome's leadership in personalized health solutions within the growing personalized nutrition and supplements market.
Scale indicators4 records
Recent moves5 records
Expansion highlights6 records
Viome Life Sciences competitors and assessment
Company assessmentDirect peers
- ZOE: ZOE is a direct competitor in at-home microbiome and personalized nutrition, combining stool metagenomics with blood and CGM data to deliver dietary recommendations. It competes head-to-head with Viome on the DTC Full Body Intelligence value proposition and target consumer.
- Thorne HealthTech: Thorne offers personalized supplement products and at-home health testing, closely overlapping with Viome's test-plus-supplement bundled model and serving similar health-conscious consumer and practitioner segments.
- InsideTracker: InsideTracker provides at-home blood biomarker analysis with AI-driven personalized nutrition and supplement recommendations, competing directly with Viome on the actionability of molecular health insights for longevity-focused consumers.
- DayTwo: DayTwo is a microbiome-based personalized nutrition company offering gut-driven glucose and dietary recommendations. It is a direct competitor in the microbiome-to-nutrition prescription use case that Viome's Gut Health PRO addresses.
Emerging players
- Function Health: Function Health sells comprehensive at-home lab panels and personalized insights to preventive-health consumers, overlapping with Viome's Full Body Intelligence Test on longitudinal biomarker testing and consumer subscription model.
Broad incumbents
- 23andMe: 23andMe is an established consumer genetic testing and health insights platform with a large installed base, overlapping with Viome on at-home molecular health insights and DTC preventive positioning, but using DNA rather than RNA methodology.
Regional players
- Atlas Biomed: Atlas Biomed offers microbiome and DNA testing with personalized health recommendations primarily to European consumers, mirroring Viome's DTC test-plus-recommendation model in a different geography.
- Cerascreen: Cerascreen sells a broad portfolio of at-home biomarker and microbiome tests across Europe, competing with Viome on the consumer testing value proposition in non-US markets at typically lower price points.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Viome Life Sciences social profiles
Digital presenceViome Life Sciences compliance and trust
Trust signalCompliance1 record
Viome Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Viome Life Sciences leadership team
Management profileNumber of profiles
Profiles1 record
Viome Life Sciences subsidiaries and ownership
Company hierarchySubsidiaries1 record
Viome Life Sciences funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Viome Life Sciences M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Viome Life Sciences
What does Viome Life Sciences do?
Viome Life Sciences provides at-home microbiome and gene expression tests that use metatranscriptomic RNA sequencing combined with an AI-driven recommendation engine to deliver personalized dietary, supplementation, and precision health insights. Through its Viome Pro channel, it offers healthcare providers molecular health tests (Precision Health PRO, Gut Health PRO, Oral Health Pro) for preventive care and early disease detection, including the only test for oral and throat cancer using molecular analysis.
Is Viome Life Sciences a public or private company?
Viome Life Sciences is a private company. It is classified as venture growth investor backed and is currently operating.
When was Viome Life Sciences founded?
Viome Life Sciences was founded in 2016. It employs 101 to 250 people.
Where is Viome Life Sciences based?
Viome Life Sciences is headquartered in Bellevue, United States, in the North America region.
How does Viome Life Sciences make money?
Three revenue lines are on record. At-home Testing Kits are the primary driver. The others are precision Health Testing (Viome Pro) and supplements/Personalized Nutrition Products.
Who are Viome Life Sciences's main competitors?
Direct peers on record are ZOE, Thorne HealthTech, InsideTracker and DayTwo. Function Health is listed as an emerging player. 23andMe is listed as a broad incumbent. Regional players are Atlas Biomed and Cerascreen.
Does Viome Life Sciences have an API?
No public API is recorded for Viome Life Sciences.
What industry is Viome Life Sciences in?
Viome Life Sciences's product category is Personalized Health Diagnostics. Its primary akta.pro industry code is HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR), with a secondary code of HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms. Its NAICS code is 621511 and its SIC code is 2835.